Will MongoDB's full-year FY2026 stock-based compensation exceed 50% of total revenue?

The prior estimate anchored at ~52% SBC/revenue based on annualized quarterly data against ~$2.437B guided revenue. Two material developments from Q4 earnings shift the probability modestly downward. First, FY2026 actual revenue came in at ~$2,462M — roughly $25M above the guidance midpoint — which reduces the ratio by approximately 0.5pp, pushing the estimated ratio toward ~51.5%. Second, and more significantly, Q4 GAAP operating income turned positive for the first time in company history. Since GAAP operating income = revenue minus all GAAP expenses including SBC, this implies Q4 SBC was low enough relative to Q4 revenue ($695M) to produce a positive number. If Q4 SBC was materially lower than prior quarters (which GAAP profitability strongly implies), the full-year SBC could come in meaningfully below the annualized estimate of ~$1.27B. A Q4 SBC figure of, say, $280M vs the implied quarterly average of ~$318M would pull the full-year SBC toward ~$1.22B — very close to the 50% threshold on $2,462M revenue. The 10-K is the only resolution mechanism, and the Q4 data introduces genuine uncertainty about whether the threshold is crossed. Still favor YES given the prior committee finding and structural SBC levels, but acknowledging the Q4 GAAP profitability signal.

The Q4 GAAP profitability signal is notable but should not be over-interpreted. GAAP operating income turning positive for one quarter does not necessarily imply dramatically lower SBC — Q4 revenue of $695M was exceptionally strong (27% YoY) including what may be a one-time $100M+ enterprise agreement that temporarily boosted Q4 above run rate. If the GAAP profitability was driven by revenue outperformance rather than SBC reduction, the full-year SBC could still be near the annualized estimate. Consider: if Q4 SBC was the same as Q3 average (~$318M per quarter), Q4 GAAP operating income would be approximately $695M × (1 - non-GAAP margin) - non-cash adjustments. The revenue bump from the EA deal alone could have produced Q4 GAAP profitability without any SBC reduction. The prior estimate of ~52% remains the most grounded figure. Revenue outperformance ($2,462M vs $2,437M) reduces the ratio slightly, but this is a ~1pp effect. Net assessment: probability modestly lower than the prior 76% batch but not dramatically so. Structural SBC levels are well-established and the committee's 'hope not finding' conclusion on normalization remains operative.

I weight the Q4 GAAP profitability signal more heavily than the other Opus runs. For context: if Q4 revenue was $695M and GAAP operating income was positive (even marginally), total Q4 operating expenses including SBC must be below $695M. The prior quarterly SBC run rate was approximately $318M/quarter, with other COGS and opex components. A quick structure: revenue $695M, COGS ~$175M (25% blended), gross profit ~$520M, R&D ~$120M, S&M ~$150M, G&A ~$50M (approximate non-GAAP scale), plus SBC allocated across these. If the SBC in Q4 was consistent with prior quarters at ~$318M and allocated across cost categories, total GAAP opex would be roughly $520M + $320M SBC-equivalent expenses = well above $695M in revenue. Therefore, GAAP profitability essentially requires either (a) Q4 SBC was substantially below $318M, or (b) other cost categories were sharply reduced. Given management commentary on operating leverage and the 100% FCF commitment to buybacks/RSU settlements starting FY2027, I believe Q4 SBC was genuinely lower, possibly $260-290M range. If so, the full-year SBC may be closer to $1.19-$1.22B, bringing the ratio toward 48-50% — squarely at the boundary. This creates meaningful 50/50 territory near the threshold, which I reflect with a 0.68 probability rather than the prior 0.76.

Two competing forces are at work since the prior batch. The revenue outperformance ($2,462M actual vs $2,437M midpoint guidance) is a modest but real downward force on the SBC/revenue ratio — it reduces the ratio from ~52.1% to ~51.6% holding SBC constant. The more significant signal is Q4 GAAP operating profitability. This is a concrete data point that changes the calculus. For GAAP operating income to be positive in Q4 with $695M revenue, the sum of all GAAP costs (COGS + R&D + S&M + G&A) must be below $695M. Prior quarters saw GAAP operating losses of approximately 30-35% of revenue, implying ~$600M+ in quarterly costs when SBC is included. A 27% revenue jump alone does not explain full elimination of this deficit unless Q4 SBC was materially lower. The net effect is that the full-year SBC figure — when it appears in the 10-K — may come in closer to $1.20-$1.24B rather than the extrapolated $1.27B. On $2,462M revenue, that range implies a ratio of 49-50.4%. The market is now genuinely close to the threshold, justifying a meaningful step down from 76%. I place probability at 72% — still favoring YES but with significantly more uncertainty.

I am the most skeptical of the YES case in this batch. The Q4 GAAP profitability event is genuinely signal-rich and is being underweighted by models anchoring to the prior 76% estimate. Here is the core math: MongoDB guided ~$667M for Q4 revenue (midpoint). Actual was $695M — a $28M beat (4.2%). This revenue outperformance on its own would reduce the SBC/revenue ratio by roughly 0.5pp. But Q4 GAAP profitability tells us something about the SBC numerator too. If we take Q4 non-GAAP operating margin at approximately 20% ($139M), and prior quarters showed GAAP margins of -30% to -35%, the gap between GAAP and non-GAAP was roughly $350M+ per quarter — which is essentially the SBC and amortization burden. For Q4 to flip GAAP positive, either (a) the gap collapsed dramatically, meaning Q4 SBC was $250M or less, or (b) the revenue surge was so large it absorbed the fixed SBC cost. Both effects together create meaningful probability that full-year SBC comes in at or below $1.22B. On $2,462M revenue, $1.22B is 49.6% — just below the 50% threshold. The committee had already noted the revenue-SBC growth rate differential, and Q4 earnings data confirms that differential is producing concrete results faster than modeled. I place probability at 66%, reflecting that the market is genuinely close to even odds near the threshold.

Balancing the prior committee findings against the new Q4 data. The prior analysis was rigorous — 5 of 7 lenses converged on SBC as a structural issue, and the committee explicitly concluded that SBC normalization was 'hope not finding.' These findings do not evaporate because of one quarter of GAAP profitability. However, Q4 GAAP profitability is precisely the kind of concrete inflection event the Atomic Auditor flagged as an 'upgrade trigger' — it demonstrates the unit economics are starting to work on a GAAP basis, even if just for one quarter. The relevant question is whether Q4 SBC was genuinely lower (structural improvement beginning) or whether Q4 revenue was just exceptionally elevated due to timing effects (EA deal, backend-loaded quarters). The 100% FCF commitment to buybacks and RSU settlements starting FY2027 suggests management is taking SBC management seriously. But commitments for FY2027 do not reduce FY2026 SBC expense. The full-year FY2026 SBC will be set by the grants already made, already vested, and already expensed. The prior annualized estimate of $1.27B is still the best single point estimate, though with wider error bars now. I place probability at 71%, modest step down from 76%.

Prior estimate: ~52% SBC/revenue. Q4 update brings two changes. Revenue actual ~$2,462M (higher denominator, ~0.5pp reduction). Q4 GAAP operating income turned positive (implies Q4 SBC was lower than quarterly average). Net effect: full-year SBC likely below $1.27B annualized estimate, possibly $1.22-$1.25B. On $2,462M revenue, $1.25B = 50.8%, $1.22B = 49.6%. Outcome is genuinely near the threshold. Prior structural findings still favor YES. Probability 73% — step down from 76%.

Q4 GAAP profitability is the key new signal. It materially constrains what Q4 SBC could have been. If Q4 SBC was around $270M (vs prior run rate of ~$318M), full-year SBC would be approximately $1.21B. On $2,462M revenue that is 49.2% — below 50%. The Q4 EA deal could explain part of the GAAP profitability via revenue alone, but the magnitude of the GAAP swing (from -30% margin to positive) is difficult to attribute entirely to revenue. Some genuine SBC reduction is implied. Probability 67%, reflecting meaningful uncertainty near the threshold.

SBC structurally elevated at ~2x peer levels and ~2.9x non-GAAP operating income. Prior committee conclusion: normalization is 'hope not finding.' But Q4 data introduces genuine ambiguity. Revenue beat ($2,462M vs $2,437M) + Q4 GAAP profitability together shift the math closer to the 50% threshold. The outcome depends on whether Q4 SBC was materially below the run rate. Prior findings are not invalidated, but the confidence in YES is reduced. Probability 70%.